Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cisatracurium]

J R Ortiz1, J A Percaz, F Carrascosa

  • 1Departamento de Anestesiología y Cuidados Intensivos, Clínica Universitaria de Navarra. Facultad de Medicina. jortizg@unav.es

Revista Espanola De Anestesiologia Y Reanimacion
|August 28, 1998
PubMed
Summary

Cisatracurium, a potent neuromuscular blocker, offers hemodynamic stability and predictable recovery. Its unique metabolism allows for consistent dosing in patients with organ dysfunction, making it ideal for intensive care and long-term surgeries.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The power of registry studies to inform maternal influenza vaccine policy and practice.

Journal of internal medicine·2019
Same author

Maternal influenza and birth outcomes: systematic review of comparative studies.

BJOG : an international journal of obstetrics and gynaecology·2016
Same author

Reply to 'What to do if the endotracheal tube will not pass through the nasal passage during fiberoptic nasotracheal intubation'.

Acta anaesthesiologica Scandinavica·2008
Same author

Comparative study of intubating conditions at the first minute with suxamethonium, rocuronium and different priming techniques of rocuronium.

European journal of anaesthesiology·2005
Same author

Cost-effectiveness of three combinations of antiemetics in the prevention of postoperative nausea and vomiting.

British journal of anaesthesia·2003
Same author

A comparison of three antiemetic combinations for the prevention of postoperative nausea and vomiting.

Anesthesia and analgesia·2002

Area of Science:

  • Anesthesiology and Pharmacology
  • Neuromuscular Pharmacology

Background:

  • Cisatracurium is a specific isomer of atracurium, known for its potency and stability.
  • Unlike atracurium, cisatracurium exhibits minimal histamine release, contributing to its hemodynamic stability.

Purpose of the Study:

  • To evaluate the efficacy and safety of cisatracurium as a neuromuscular blocking agent.
  • To highlight cisatracurium's suitability for specific patient populations and surgical durations.

Main Methods:

  • Pharmacokinetic and pharmacodynamic analysis of cisatracurium.
  • Comparison of cisatracurium's effects with atracurium and rocuronium.
  • Assessment of cisatracurium's utility in intensive care and surgical settings.

Main Results:

  • Cisatracurium is significantly more potent than atracurium and demonstrates excellent hemodynamic stability.
  • Metabolism primarily via Hofmann elimination (77%) and secondarily by kidneys (16%) ensures dose consistency across patient groups.
  • While higher doses shorten intubation time, recovery from blockade is dose-independent and rapid.

Conclusions:

  • Cisatracurium is a preferred non-depolarizing muscle relaxant for extended surgeries and critically ill patients due to its stability and predictable recovery.
  • Its favorable metabolic profile reduces the need for dose adjustments in patients with hepatic, renal, or cardiovascular compromise.
  • Cisatracurium offers a valuable option for neuromuscular blockade in intensive care settings.

Related Experiment Videos